 |
Prospector
Profile
3-17-002
|
| |
| Diomed Holdings, Inc. |
NAICS |
334510 |
| 1 Dundee Park
Andover, MA 01810 |
Description |
Pharmaceutical Mfg. |
| (978) 475-7771 |
Employees |
100 |
| http://www.diomedinc.com/ |
Revenue |
(mil) |
22.3800 |
| |
Income |
(mil) |
-10.2700 |
| |
Assets |
(mil) |
23.8400 |
| |
Liability |
(mil) |
28.0200 |
| |
(for the year ended 2006-12-31) |
| |
|
Category:
Bankruptcy
|
| |
|
Event:
Diomed Holdings, Inc. and its Diomed. Inc. subsidiary filed separate Chapter 11 petitions on March 14, 2008, with the Bankruptcy Court for the District of Massachusetts, case numbers 08-40749 and 08-40750, Judge Joel
B. Rosenthal presiding.
|
| |
|
Intellectual Property:
The Company holds U.S. and international patents for inventions related to endovenous laser treatment of varicose veins, solid state laser diode light source, high power light source, peltier-cooled and medical spacing guide. The Company licensed technology for the EVLT(R) process from one of its inventors, Dr. Robert Min, on a non-exclusive basis. On September 3, 2003, Diomed acquired exclusive rights to U.S. Patent No. 6,398,777 and related foreign patents for endovenous laser treatment of varicose veins. The Company also invented fiber technology used with its EVLT(R) products. In January 2006, the U.S. Patent and Trademark Office issued two additional patents used in connection with EVLT(R), for the introducer sheath/optical fiber arrangement that may be used in the endovascular laser treatment of varicose veins. The Company licenses technology currently used in its OPTIGUIDE(R) fiber optic diffuser from Health Research, Inc.. The Company has received trademark registrations for the trademarks Diomed, OPTIGUIDE and EVLT. It has initiated trademark registrations for Summer Legs, Spotlight and Spotlight OPS as a trademark and/or service mark. The Company has registered various domain names, including diomedinc.com, diomed-lasers.com, fibersdirect.com, fibresdirect.com, summerlegs.com and evlt.com. [SEC Filing 10-K 03-19-07]
|
| |
|
Description:
Diomed Holdings, Inc., through its subsidiaries, engages in the development and commercialization of minimally invasive medical procedures that employ its laser technologies and associated disposable products.
|
| |
|
Officers:
James A. Wylie, Jr. (Pres., CEO & Dir.); David Swank (CFO & Dir.); Geoffrey Jenkins (Dir.); Sidney Braginsky (Dir.); Gary Brooks (Dir.); A. Kim Campbell (Dir.); Joseph Harris (Dir.); Peter Klein (Dir.); Edwin Snape, Ph. D. (Dir.)
|
| |
|
Auditor:
BDO Seidman LLP
|
| |
|
Attorneys:
Douglas R. Gooding, Esq., at Choate, Hall & Stewart; Boston, Mass.; (617) 248-5000
|
| |
|
Securities:
Common Stock-Symbol DIO; AMEX;
30,318,331 common shares outstanding as of November 13 , 2007.
|
| |
|
Notes:
When the Company filed for Chapter 11 protection, it listed estimated assets of less than $10,000 and estimated debts of $1 million to $10 million. Diomed, Inc., listed estimated assets of $10 million to $50 million and estimated debts of $10 million to $50 million.
|
| |
| |
| return to main page |
|
|
